Intuitive Surgical (ISRG) Stock Price

Intuitive Surgical Price

NASDAQ·CLOSED
373.71USD-0.83 (-0.22 %)
Market closed

Over the last 19 years Intuitive Surgical grew revenue by 18.9% annually, reaching 10.06 B USD. Earnings per share have grown at 20.9% per year over the last 19 years. For Intuitive Surgical, the net margin of 28.4% is down versus 29.9% a few years ago. The consensus 12-month price target for Intuitive Surgical is 627.81 USD, about 68.0% above where the stock trades today. Of 42 analysts, 29 rate the stock a buy — an overall Buy consensus. The stock trades about 13% above its 52-week low.

Intuitive Surgical stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Intuitive Surgical over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Intuitive Surgical stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Intuitive Surgical's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Intuitive Surgical Stock Price History
DateIntuitive Surgical Price
8/6/2026373.71 USD
8/5/2026374.54 USD
8/4/2026366.65 USD
8/3/2026375.41 USD
7/31/2026353.33 USD
7/30/2026352.97 USD
7/29/2026356.54 USD
7/27/2026355.87 USD
7/23/2026332.02 USD
7/22/2026340.69 USD
7/21/2026350.06 USD
7/20/2026353.17 USD
7/17/2026345.42 USD
7/16/2026402.33 USD
7/15/2026388.97 USD
7/14/2026379.50 USD
7/13/2026411.15 USD
7/10/2026406.78 USD
7/9/2026411.55 USD
7/8/2026420.38 USD
7/7/2026427.30 USD
7/6/2026424.77 USD
7/2/2026426.01 USD
7/1/2026402.38 USD
6/30/2026397.68 USD
6/29/2026407.64 USD
6/26/2026404.70 USD
6/25/2026399.69 USD
6/24/2026401.83 USD
6/23/2026403.18 USD
6/22/2026402.38 USD
6/18/2026406.90 USD
6/17/2026412.64 USD
6/16/2026420.00 USD
6/15/2026416.02 USD
6/12/2026409.65 USD
6/11/2026407.98 USD
6/10/2026419.96 USD
6/9/2026426.61 USD
6/8/2026418.61 USD
6/5/2026424.05 USD
6/4/2026416.09 USD
6/3/2026400.12 USD
6/2/2026401.61 USD
6/1/2026416.68 USD
5/29/2026421.58 USD
5/28/2026420.75 USD
5/27/2026427.92 USD
5/26/2026437.35 USD
5/22/2026436.44 USD
5/21/2026438.57 USD
5/20/2026445.63 USD
5/19/2026441.58 USD
5/18/2026439.92 USD
5/15/2026421.12 USD
5/14/2026428.06 USD
5/13/2026432.27 USD
5/12/2026431.87 USD
5/11/2026420.06 USD
5/8/2026450.06 USD
5/7/2026453.49 USD
5/6/2026451.73 USD
5/5/2026451.38 USD
5/4/2026452.35 USD
5/1/2026457.78 USD
4/30/2026457.61 USD
4/29/2026453.83 USD
4/28/2026466.64 USD
4/27/2026470.99 USD
4/24/2026482.22 USD
4/23/2026478.82 USD
4/22/2026483.62 USD
4/21/2026451.29 USD
4/20/2026465.60 USD
4/17/2026469.21 USD
4/16/2026458.08 USD
4/15/2026468.36 USD
4/14/2026467.22 USD
4/13/2026458.96 USD
4/10/2026450.62 USD
4/9/2026454.94 USD
4/8/2026462.28 USD
4/7/2026452.95 USD
4/6/2026452.58 USD
4/2/2026454.29 USD
4/1/2026464.45 USD
3/31/2026460.99 USD
3/30/2026452.78 USD
3/27/2026451.37 USD
3/26/2026469.01 USD
3/25/2026469.98 USD
3/24/2026475.25 USD
3/23/2026478.04 USD
3/20/2026482.02 USD
3/19/2026479.93 USD
3/18/2026479.93 USD
3/17/2026482.76 USD
3/16/2026483.46 USD
3/13/2026472.16 USD
3/12/2026478.06 USD
3/11/2026491.01 USD
3/10/2026485.85 USD
3/9/2026493.25 USD
3/6/2026491.01 USD
3/5/2026496.70 USD
3/4/2026501.18 USD
3/3/2026497.42 USD
3/2/2026496.25 USD
2/27/2026503.51 USD
2/26/2026506.88 USD
2/25/2026506.17 USD
2/24/2026494.02 USD
2/23/2026492.10 USD
2/20/2026504.36 USD
2/19/2026499.53 USD
2/18/2026500.26 USD
2/17/2026493.35 USD
2/13/2026485.84 USD
2/12/2026480.80 USD
2/11/2026496.12 USD
2/10/2026495.15 USD
2/9/2026492.84 USD
2/6/2026487.51 USD
2/5/2026476.32 USD
2/4/2026478.49 USD
2/3/2026478.88 USD
2/2/2026496.73 USD
1/30/2026504.22 USD
1/29/2026506.51 USD
1/28/2026522.04 USD
1/27/2026524.51 USD
1/26/2026528.81 USD
1/23/2026523.51 USD
1/22/2026540.01 USD
1/21/2026524.88 USD
1/20/2026527.44 USD
1/16/2026533.35 USD
1/15/2026541.34 USD
1/14/2026545.06 USD
1/13/2026561.82 USD
1/12/2026572.75 USD
1/9/2026586.25 USD
1/8/2026585.08 USD
1/7/2026590.01 USD
1/6/2026593.99 USD
1/5/2026566.38 USD
1/2/2026561.98 USD
12/31/2025566.36 USD
12/30/2025572.63 USD
12/29/2025575.40 USD
12/26/2025578.01 USD
12/24/2025577.15 USD
12/23/2025577.34 USD
12/22/2025579.83 USD
12/19/2025572.47 USD
12/18/2025561.89 USD
12/17/2025557.94 USD
12/16/2025554.59 USD
12/15/2025559.52 USD
12/12/2025543.01 USD
12/11/2025548.29 USD
12/10/2025555.92 USD
12/9/2025556.40 USD
12/8/2025566.89 USD
12/5/2025575.56 USD
12/4/2025568.63 USD
12/3/2025570.41 USD
12/2/2025567.72 USD
12/1/2025567.37 USD
11/28/2025573.48 USD
11/26/2025574.23 USD
11/25/2025579.83 USD
11/24/2025567.72 USD
11/21/2025561.61 USD
11/20/2025542.12 USD
11/19/2025562.85 USD
11/18/2025545.14 USD
11/17/2025546.71 USD
11/14/2025550.01 USD
11/13/2025566.27 USD
11/12/2025572.45 USD
11/11/2025574.31 USD
11/10/2025576.21 USD
11/7/2025561.06 USD
11/6/2025546.99 USD
11/5/2025548.55 USD
11/4/2025539.83 USD
11/3/2025544.21 USD
10/31/2025538.01 USD
10/30/2025530.02 USD
10/29/2025537.59 USD
10/28/2025542.41 USD
10/27/2025551.25 USD
10/24/2025545.02 USD
10/23/2025546.26 USD
10/22/2025527.03 USD
10/21/2025542.94 USD
10/20/2025458.47 USD
10/17/2025447.21 USD
10/16/2025433.12 USD
10/15/2025435.61 USD
10/14/2025436.39 USD
10/13/2025435.73 USD
10/10/2025428.95 USD
10/9/2025443.76 USD
10/8/2025450.51 USD
10/7/2025440.94 USD
10/6/2025449.69 USD
10/3/2025451.91 USD
10/2/2025443.01 USD
10/1/2025441.01 USD
9/30/2025447.23 USD
9/29/2025439.22 USD
9/28/2025439.22 USD
9/25/2025441.12 USD
9/24/2025438.12 USD
9/23/2025450.81 USD
9/22/2025444.55 USD
9/19/2025438.73 USD
9/18/2025436.52 USD
9/17/2025433.66 USD
9/16/2025434.50 USD
9/15/2025434.02 USD
9/12/2025450.01 USD
9/11/2025455.85 USD
9/10/2025450.43 USD
9/9/2025465.02 USD
9/8/2025470.00 USD
9/5/2025467.26 USD
9/4/2025454.51 USD
9/3/2025441.18 USD
9/2/2025469.07 USD
8/29/2025473.16 USD
8/28/2025473.84 USD
8/27/2025471.15 USD
8/26/2025474.26 USD
8/25/2025468.44 USD
8/22/2025476.83 USD
8/21/2025469.88 USD
8/20/2025480.45 USD
8/19/2025479.20 USD
8/18/2025481.28 USD
8/15/2025480.27 USD
8/14/2025477.08 USD
8/13/2025482.35 USD
8/12/2025478.19 USD
8/11/2025471.85 USD
8/8/2025470.36 USD
8/7/2025469.81 USD
Access this data via the Eulerpool API
Get Free API Key

Intuitive Surgical Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
7.12 B USD
1.77 B USD
1.80 B USD
Jan 1, 2024
8.35 B USD
2.35 B USD
2.32 B USD
Jan 1, 2025
10.06 B USD
2.95 B USD
2.86 B USD
Jan 1, 2026 (e)
11.76 B USD
3.56 B USD
3.82 B USD
Jan 1, 2027 (e)
13.28 B USD
4.02 B USD
4.28 B USD
Jan 1, 2028 (e)
15.03 B USD
4.55 B USD
4.81 B USD
Jan 1, 2029 (e)
17.04 B USD
5.16 B USD
5.56 B USD
Jan 1, 2030 (e)
18.49 B USD
5.60 B USD
6.04 B USD

Intuitive Surgical Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 7, 2026, 7:00 AM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB USD
EBITB USD
EBIT MARGIN%
NET INCOMEB USD
NET INCOME GROWTH%
SHARESM
201520162017201820192020202120222023202420252026e2027e2028e2029e2030e
2.382.703.133.724.484.365.716.227.128.3510.0611.7613.2815.0317.0418.49
11.8713.4215.6819.0520.25-2.6831.028.9714.5017.2420.5016.8612.8913.2013.368.53
66.1569.9070.1469.9269.4565.6569.3267.4466.3867.4666.0066.0066.0066.0066.0066.00
1.581.892.192.603.112.863.964.204.735.636.647.768.769.9211.2412.20
0.740.951.051.201.371.051.821.581.772.352.953.564.024.555.165.60
31.0434.9533.7032.2030.6824.0731.8925.3524.7928.1129.2630.2630.2630.2730.2730.27
0.590.740.661.131.381.061.701.321.802.322.863.824.284.815.566.04
40.6725.00-10.2070.7622.36-23.1360.75-22.4236.0129.1423.0033.8911.7912.4015.738.56
342.90358.20336.60345.00359.10363.30367.40357.00358.20363.90360.40360.40360.40360.40360.40360.40
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Intuitive Surgical generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Intuitive Surgical retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Intuitive Surgical's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Intuitive Surgical has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Intuitive Surgical's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Intuitive Surgical stock margins

The Intuitive Surgical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Intuitive Surgical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Intuitive Surgical.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
69.32 %
31.89 %
29.85 %
Jan 1, 2022
67.44 %
25.35 %
21.25 %
Jan 1, 2023
66.39 %
24.80 %
25.24 %
Jan 1, 2024
67.46 %
28.12 %
27.81 %
Jan 1, 2025
66.00 %
29.27 %
28.38 %
Jan 1, 2026 (e)
66.00 %
30.27 %
32.52 %
Jan 1, 2027 (e)
66.00 %
30.27 %
32.20 %
Jan 1, 2028 (e)
66.00 %
30.27 %
31.97 %

Intuitive Surgical Stock Revenue, EBIT, Earnings per Share

The Intuitive Surgical earnings per share therefore indicates how much revenue Intuitive Surgical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
15.54 USD
4.96 USD
4.64 USD
Jan 1, 2022
17.43 USD
4.42 USD
3.70 USD
Jan 1, 2023
19.89 USD
4.93 USD
5.02 USD
Jan 1, 2024
22.95 USD
6.45 USD
6.38 USD
Jan 1, 2025
27.93 USD
8.17 USD
7.92 USD
Jan 1, 2026 (e)
33.12 USD
9.88 USD
10.77 USD
Jan 1, 2027 (e)
37.39 USD
11.15 USD
12.04 USD
Jan 1, 2028 (e)
42.33 USD
12.62 USD
13.53 USD

Intuitive Surgical business model & stock analysis

Intuitive Surgical Inc is an American company that specializes in the manufacturing of medical robots. The company was founded by Friedman and Green in 1995 and is headquartered in Sunnyvale, California. Starting with the goal of improving and making laparoscopic surgery more efficient, the company has since expanded its offerings and distributes its robots in many countries worldwide. Intuitive Surgical's business model is based on surgeons purchasing the robots and, in some cases, operating them. The cost of a robot can be very high, but this is balanced out by the efficiency achieved through the use of the robots. One of the main advantages of Intuitive Surgical is the fact that the robots have higher precision than traditional surgery. There is less blood loss, less scarring, and therefore a shorter recovery time for the patient. The company has two main products, the Da Vinci System for laparoscopic surgery and the Ion Robotic System for endoscopy. The Da Vinci robot was Intuitive Surgical's first product and was introduced to the market in 2000. The Da Vinci robots are used for a variety of surgeries and provide better visualization and precision for the surgeon. The robot is operated through a console at which the surgeon sits and connects to the robot's instruments. The Ion robot, on the other hand, was recently introduced and is meant for endoscopy. The system offers more precise imaging and the ability to better position the endoscope. The robot also has the capability to extract and analyze biological samples and tissues from the patient. Intuitive Surgical also offers a variety of accessories, such as instruments, consoles, docking stations, and software. The instruments vary depending on the application, ranging from scissors and needle holders to graspers and clippers. The docking stations allow for automatic switching of instruments without the surgeon having to manually change them. The software is used to facilitate the control of the robots and instruments and support data processing. Since its founding in the 1990s, Intuitive Surgical has experienced impressive growth. In 2000, the company had only 14 employees and introduced the Da Vinci robot. Today, the company employs over 5,000 people and sells its products in more than 60 countries worldwide. The company has become a market leader in laparoscopic surgery and has won a variety of awards and accolades. The company is also highly committed to research and development. There is a team of engineers, scientists, and surgeons constantly working to improve the robots and instruments and develop new applications. Intuitive Surgical also has partnerships with leading healthcare companies in the industry to promote collaboration and knowledge exchange. Overall, Intuitive Surgical has had a significant impact on medical care and laparoscopic surgery. The company's robots have already helped many patients receive better medical care and recover faster. Collaboration with other industry experts and ministries also helps optimize the use of the technology and improve patient access to this technology.

Intuitive Surgical SWOT Analysis

Strengths

Intuitive Surgical Inc benefits from being a market leader in the development and manufacturing of robotic surgical systems. Its flagship product, the da Vinci Surgical System, has set the standard for advanced minimally invasive surgery, providing superior precision and control to surgeons.

The company offers a diverse range of robotic surgical systems and related instruments, enabling it to cater to various medical specialties. This comprehensive product portfolio enhances Intuitive Surgical's competitive advantage and allows it to address the needs of different surgeons and hospitals effectively.

Intuitive Surgical has built a loyal and expanding customer base, comprising hospitals, surgical centers, and healthcare professionals worldwide. The company's innovative technology and proven track record have instilled trust and confidence in its customers, leading to continued strong demand for its products.

Weaknesses

The da Vinci Surgical System and its associated instruments come with a significant price tag, making them expensive investments for hospitals and healthcare institutions. Additionally, the ongoing maintenance costs can pose financial challenges for customers, potentially limiting the company's market penetration in cost-sensitive regions or facilities.

While Intuitive Surgical's technology is widely used across various surgical fields, the majority of its revenue still relies heavily on specific procedures such as prostatectomy and hysterectomy. This concentration exposes the company to risks associated with changes in medical practices, reimbursement policies, or competing technologies.

Opportunities

Intuitive Surgical can explore untapped opportunities in emerging markets, where robotic-assisted surgery adoption is still in its early stages. By expanding its presence and offering flexible pricing options tailored to the local market dynamics, the company can capitalize on the growing demand for advanced surgical technologies.

The field of robotic surgery is rapidly evolving, presenting Intuitive Surgical with opportunities to further enhance its product offerings and maintain its technological leadership. By investing in research and development, the company can introduce innovative features, improve surgical outcomes, and expand into new surgical applications.

Threats

Intuitive Surgical faces intense competition from both established medical device companies and emerging players in the robotic surgical market. Competitors may develop comparable or superior technologies, potentially eroding the market share and pricing power of Intuitive Surgical's products.

The regulatory environment and reimbursement policies surrounding robotic surgery can pose challenges for Intuitive Surgical. Changes in regulations, reimbursement rates, or insurance coverage may impact the adoption and financial viability of its products, affecting the company's revenue and competitive position.

Intuitive Surgical Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Intuitive Surgical Employees
Details
Date
Intuitive Surgical Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Intuitive Surgical Segments

Intuitive Surgical Revenue by Segment (1/3)

  • 3 Years

  • 5 Years

  • Max

Product
Service
Details
Date
Product
Service
Jan 1, 2018
3.09 B USD
635.10 M USD
Jan 1, 2019
3.75 B USD
724.20 M USD
Jan 1, 2020
3.63 B USD
723.80 M USD
Jan 1, 2021
4.79 B USD
916.20 M USD
Jan 1, 2022
0.00 USD
0.00 USD
Jan 1, 2023
5.96 B USD
1.17 B USD
Jan 1, 2024
7.05 B USD
1.31 B USD
Jan 1, 2025
8.49 B USD
1.57 B USD

Intuitive Surgical Revenue by Segment (2/3)

  • 3 Years

  • 5 Years

  • Max

Product
Instruments and accessories
Systems
Service
Services
Details
Date
Product
Instruments and accessories
Systems
Service
Services
Jan 1, 2018
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2019
0.00 USD
2.41 B USD
1.35 B USD
0.00 USD
724.20 M USD
Jan 1, 2020
0.00 USD
2.46 B USD
1.18 B USD
0.00 USD
723.80 M USD
Jan 1, 2021
0.00 USD
3.10 B USD
1.69 B USD
0.00 USD
916.20 M USD
Jan 1, 2022
5.20 B USD
0.00 USD
0.00 USD
1.02 B USD
0.00 USD
Jan 1, 2023
0.00 USD
4.28 B USD
1.68 B USD
0.00 USD
0.00 USD
Jan 1, 2024
0.00 USD
5.08 B USD
1.97 B USD
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
6.02 B USD
2.47 B USD
0.00 USD
0.00 USD

Intuitive Surgical Revenue by Segment (3/3)

  • 3 Years

  • 5 Years

  • Max

Instruments and accessories
Systems
Services
Details
Date
Instruments and accessories
Systems
Services
Jan 1, 2018
1.96 B USD
1.13 B USD
635.10 M USD
Jan 1, 2019
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2020
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2022
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2023
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2024
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
0.00 USD
0.00 USD

Intuitive Surgical Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Intuitive Surgical historical P/E ratio, EBIT multiple, and P/S ratio

Intuitive Surgical annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Intuitive Surgical shares outstanding

The number of shares of Intuitive Surgical was 360.4 M in 2025. This indicates how many shares Intuitive Surgical is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
367.40 M Stocks
Jan 1, 2022
357.00 M Stocks
Jan 1, 2023
358.20 M Stocks
Jan 1, 2024
363.90 M Stocks
Jan 1, 2025
360.40 M Stocks
Jan 1, 2026 (e)
360.40 M Stocks
Jan 1, 2027 (e)
360.40 M Stocks
Jan 1, 2028 (e)
360.40 M Stocks

Intuitive Surgical stock splits

In Intuitive Surgical's history, there have been no stock splits.

Current Intuitive Surgical forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.49 %
Buy
69.05 % (29)
Hold
28.57 % (12)
Sell
2.38 % (1)
12M Price Target
627.81
Last Price
373.71
Currency
USD
12M Return Potential
67.99 %
LTM Return
0 %

Intuitive Surgical Analyst Rating Actions

DateFirmActionRatingReliability
7/17/2026
Wells Fargo
Wells Fargo
MaintainedOverweight56
7/17/2026
TD Cowen
TD Cowen
MaintainedBuy60
7/17/2026
Stifel
Stifel
MaintainedBuy–
7/17/2026
RBC Capital
RBC Capital
MaintainedOutperform52
7/17/2026
Raymond James
Raymond James
MaintainedOutperform74
7/17/2026
Piper Sandler
Piper Sandler
MaintainedOverweight51
7/17/2026
Mizuho
Mizuho
MaintainedNeutral31
7/17/2026
Leerink Partners
Leerink Partners
MaintainedOutperform–
7/17/2026
JP Morgan
JP Morgan
MaintainedOverweight80
7/17/2026
Evercore ISI Group
Evercore ISI Group
MaintainedIn Line62

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Intuitive Surgical Earnings Calls

2025
2024

Intuitive Surgical Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
7/16/20262.55USD-2.88 BUSD-2026 Q2
4/21/20262.16USD-2.67 BUSD-2026 Q1
1/22/20262.30USD-2.80 BUSD-2025 Q4
4/16/20241.51USD-1.93 BUSD-2024 Q1
1/22/20241.50USD-1.91 BUSD-2023 Q4
7/19/20231.37USD-1.75 BUSD-2023 Q2
4/19/20231.29USD-1.65 BUSD-2023 Q1
1/18/20231.28USD-1.71 BUSD-2022 Q4
10/18/20221.14USD-1.54 BUSD-2022 Q3
7/21/20221.21USD-1.58 BUSD-2022 Q2
...

EESG©

Eulerpool ESG Scorecard© for the Intuitive Surgical stock

63/100
53
Environment
86
Social
51
Governance
E

Environment

20
Scope 1 - Direct Emissions8,105
Scope 2 - Indirect emissions from purchased energy25,382
Scope 3 - Indirect emissions within the value chain558,786
Total CO₂ emissions33,487
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides—
Palm Oil
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees38.6
Percentage of women in management—
Percentage of Asian employees36.5
Share of Asian management32
Percentage of Hispanic/Latino employees11.7
Hispano/Latino Management share8
Percentage of Black employees5.6
Black Management Share4
Percentage of white employees42.5
White Management Share52.8
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Intuitive Surgical shareholder structure

% Name
8.46898%
BLACKROCK, INC.
BLACKROCK, INC.
6.49888%
VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC
4.46230%
STATE STREET CORP
STATE STREET CORP
3.52547%
PRICE T ROWE ASSOCIATES INC /MD/
PRICE T ROWE ASSOCIATES INC /MD/
2.38416%
GEODE CAPITAL MANAGEMENT, LLC
GEODE CAPITAL MANAGEMENT, LLC
2.26622%
CAPITAL WORLD INVESTORS
CAPITAL WORLD INVESTORS
...

Intuitive Surgical Beneficial Ownership Filings (SEC 13D/G)

Free Float
99.4%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
11.00%
Baillie Gifford & Co (Scottish partnership)
Baillie Gifford & Co (Scottish partnership)
SEC ↗
11.00%
Sands Capital Management, LLC
Sands Capital Management, LLC
SEC ↗
9.56%
Edward C. Johnson 3d
Edward C. Johnson 3d
SEC ↗
8.62%
BlackRock for purposes of Schedule 13G filings.
BlackRock for purposes of Schedule 13G filings.
SEC ↗
7.90%
Intuitive Surgical, Inc.*
Intuitive Surgical, Inc.*
SEC ↗
7.86%
The Vanguard Group - 23-1945930
The Vanguard Group - 23-1945930
SEC ↗
7.49%
Vanguard Capital Management
Vanguard Capital Management
SEC ↗
7.40%
(1) BlackRock, Inc.
(1) BlackRock, Inc.
SEC ↗
6.90%
52-0556948
52-0556948
SEC ↗
6.09%
FMR LLC
FMR LLC
SEC ↗

Intuitive Surgical Executives and Management Board

18 members · avg. age 60 · 33 % women

DR

Mr. David Rosa (57)

Chief Executive Officer, Director · since 2011

13.76 M USD

Management

JS

Mr. Jamie Samath (54)

Executive Vice President, Chief Financial Officer, Head of Business Technology

7.03 M USD
HC

Mr. Henry Charlton (55)

Executive Vice President, Chief Commercial and Marketing Officer

6.47 M USD
BM

Mr. Brian Miller (50)

Executive Vice President, Chief Digital Officer

6.20 M USD
BD

Mr. Bob DeSantis (60)

Executive Vice President, Chief Strategy and Corporate Operations Officer

4.84 M USD
MC

Dr. Myriam Curet (68)

Executive Vice President, Chief Medical Officer

4.48 M USD
GL

Mr. Gary Loeb (55)

Executive Vice President, Chief Legal and Compliance Officer

–

Board of Directors

GG

Dr. Gary Guthart (59)

Executive Chairman of the Board · since 2002

18.20 M USD
CB

Dr. Craig Barratt (62)

Lead Independent Director

466,664.00 USD
AJ

Ms. Amal Johnson (72)

Independent Director

365,736.00 USD
JN

Ms. Jami Nachtsheim (66)

Independent Director

361,569.00 USD
KL

Mr. Keith Leonard (63)

Independent Director

358,236.00 USD
AL

Dr. Amy Ladd (67)

Independent Director

355,736.00 USD

Intuitive Surgical Supply Chain

Intuitive Surgical Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
9 companies
#Nameβ 1YTrend
1
Surgical Science Sweden
Supplier·Health Care Equipment & Supplies·SE
-0.41
0.86
0.84
0.89
0.78
0.89
—
2
Lisi
Supplier·Aerospace & Defense·FR
0.05
0.57
0.67
0.55
0.48
0.67
0.59
3
Shanghai Fosun Pharm H
Supplier·Customer·CN
0.07
0.34
0.23
0.32
0.39
0.50
—
4
Synektik
Supplier·Customer·Health Care Technology·PL
-0.16
0.38
0.47
0.33
0.24
0.46
—
5
Luna Innovations Incorporated
Supplier·Electronic Equipment, Instruments & Components·US
0.51
0.39
0.80
0.90
0.72
0.43
—
#Nameβ 1YTrend
1
Clearwater Analytics A
Supplier·Software·US
0.28
0.81
0.79
0.74
—
—
—
2
Hill-Rom Holdings, Inc.
Supplier·Customer·US
0.22
-0.04
-0.63
-0.76
-0.75
—
—
3
Surgical Science Sweden AB (publ)
Supplier
0.16
—
—
—
—
—
—
4
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Supplier
-0.32
0.29
-0.05
0.67
0.58
—
—

Frequently asked questions about Intuitive Surgical

The business model of Intuitive Surgical Inc. revolves around the development, manufacturing, and marketing of robotic-assisted surgical systems. Intuitive Surgical's flagship product, the da Vinci Surgical System, enables surgeons to perform minimally invasive surgery with enhanced precision, control, and visualization. By combining robotics, software, and surgical expertise, Intuitive Surgical aims to provide innovative solutions that improve patient outcomes, reduce surgical complexity, and enhance the capabilities of healthcare professionals. Intuitive Surgical Inc. continually invests in research and development to expand its product portfolio and remains committed to supporting surgeons and hospitals worldwide in delivering advanced surgical care.

Intuitive Surgical Inc is primarily active in the medical device and healthcare industries.

Intuitive Surgical Inc faces competition from companies such as TransEnterix Inc, Medtronic Plc, and Johnson & Johnson in the market.

Intuitive Surgical Inc is a renowned American company specializing in robotic-assisted surgical systems. Founded in 1995, the company has a rich history of innovation and is widely recognized for its flagship product, the da Vinci Surgical System. This advanced technology revolutionized minimally invasive surgery by providing surgeons with enhanced precision and control. Intuitive Surgical Inc has continuously improved its robotic systems over the years, expanding its applications to various surgical specialties. The company's commitment to research, development, and training has positioned it as a global leader in robotic surgery, benefiting both patients and healthcare professionals worldwide.

Intuitive Surgical Inc has achieved several significant milestones. One notable achievement was the development of the da Vinci Surgical System, a groundbreaking robotic surgical platform that enables surgeons to perform minimally invasive procedures with enhanced precision. The company also introduced the da Vinci Xi System, which offers expanded capabilities and versatility. Moreover, Intuitive Surgical Inc has expanded its global presence by installing over 5,500 da Vinci Systems worldwide. These milestones have solidified Intuitive Surgical Inc's position as a leader in robotic-assisted surgery, providing advanced technology that improves patient outcomes and revolutionizes the healthcare industry.

Intuitive Surgical Inc primarily operates in various countries and regions worldwide. The company has a strong presence in the United States, where it is headquartered. Additionally, Intuitive Surgical Inc has established a significant market presence in Europe, particularly in countries like Germany, France, and the United Kingdom. The company also operates in other parts of the world, including Australia, Japan, China, and South Korea. With its innovative robotic surgical systems and instruments, Intuitive Surgical Inc continues to expand its global footprint, delivering advanced healthcare solutions to patients and healthcare professionals across different regions.

Intuitive Surgical Inc represents values and a corporate philosophy centered around innovation, patient care, and technological advancements in the field of robotic-assisted surgery. As a leading company in the medical industry, Intuitive Surgical Inc is committed to improving surgical outcomes, enabling minimally invasive procedures, and enhancing the overall patient experience. With their flagship product, the da Vinci Surgical System, Intuitive Surgical Inc has revolutionized the way complex surgeries are performed. By combining their cutting-edge technology and a dedication to continuous improvement, Intuitive Surgical Inc strives to provide healthcare professionals with tools that optimize surgical precision, efficiency, and ultimately, patient outcomes.

Analysts currently set an average price target of 625.53 USD for the Intuitive Surgical stock (median: 627.81 USD), implying +67.4 % versus the latest price. The consensus is based on 42 analyst ratings.

Intuitive Surgical Analyst Price Targets 2026

42 analysts currently rate the Intuitive Surgical stock: 29 recommend buying, 12 holding and 1 selling. For 2026, analysts expect Intuitive Surgical to generate revenue of 11.76 B USD and earnings per share of 10.61 USD.

Intuitive Surgical Analyst Price Targets 2026

Converted at the current exchange rate, the Intuitive Surgical share trades at 324.12 EUR (373.71 USD).

The Intuitive Surgical share (ISRG) is listed on 13 stock exchanges, including: NASDAQ (ISRG), XETRA (IUI1.DE), Frankfurt (IUI1.F), München (IUI1.MU), Stuttgart (IUI1.SG), Düsseldorf (IUI1.DU), Berlin (IUI1.BE), Hamburg (IUI1.HM).

Intuitive Surgical Inc. is a leading company specializing in medical technology, focused on the development and manufacture of robotic systems for surgical procedures. The company is headquartered in Sunnyvale, California and was founded in 1995.

The expected revenue of Intuitive Surgical is 11.76 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Intuitive Surgical is 3.82 B USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Intuitive Surgical is currently 35.22. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Intuitive Surgical stock.

The price-to-sales ratio (P/S) of Intuitive Surgical is currently 11.45. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Intuitive Surgical stock.

The Eulerpool Quality Score for Intuitive Surgical is 8/10.

The ISIN of Intuitive Surgical is US46120E6023. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Intuitive Surgical is 888024. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Intuitive Surgical is ISRG. The ticker symbol is used to trade Intuitive Surgical shares on the stock exchange.

Intuitive Surgical paid dividends every year for the past 0 years.

Intuitive Surgical is assigned to the 'Health' sector.

The dividends of Intuitive Surgical are distributed in USD.

All fundamentals and in-depth analysis of Intuitive Surgical

Our stock analysis for Intuitive Surgical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Intuitive Surgical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Intuitive Surgical Stock
Intuitive Surgical Revenue→
Intuitive Surgical Stock
Intuitive Surgical Net Income→
Intuitive Surgical Stock
Intuitive Surgical P/E→
Intuitive Surgical Stock
Intuitive Surgical P/S→
Intuitive Surgical Stock
Intuitive Surgical EBIT→
Intuitive Surgical Stock
Intuitive Surgical Dividend→
Intuitive Surgical Stock
Intuitive Surgical Directors Dealings→
Intuitive Surgical Stock
Intuitive Surgical Stocks→
Intuitive Surgical Stock
Intuitive Surgical Market capitalization→
Intuitive Surgical Stock
Intuitive Surgical Debt→
Intuitive Surgical Stock
Intuitive Surgical Liabilities→
Intuitive Surgical Stock
Intuitive Surgical Equity→
Intuitive Surgical Stock
Intuitive Surgical AAQS→
Intuitive Surgical Stock
Intuitive Surgical Employees→
Intuitive Surgical Stock
Intuitive Surgical ROE→
Intuitive Surgical Stock
Intuitive Surgical ROA→
Intuitive Surgical Stock
Intuitive Surgical ROCE→
Intuitive Surgical Stock
Intuitive Surgical News→
Intuitive Surgical Stock
Intuitive Surgical Analyst Price Targets→

Health Stocks

Invech HoldingsiNtRON BiotechnologyInvent Medic SwedenIntrasenseInventage LabIntoCellInventionmedIntervaccInventisBio CoInterpace BiosciencesInventivaInterojo CoAll Stocks A–Z →